Sresta Natural Bioproducts has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise up to Rs 500 crore through an initial public offering (IPO). The equity shares of the company are proposed to be listed on BSE and NSE.
The company proposes to utilise the net proceeds from the fresh issue towards funding the working capital requirements, repayment of debt and general corporate purposes. JM Financial and Axis Capital are the book running lead managers to the issue.
Sresta Natural Bioproducts is engaged in the business of procuring, processing, manufacturing, marketing and research and development of organic food products.
| Company Name | CMP |
|---|---|
| Venkys India | 1683.25 |
| Mangalam Global Ent | 13.82 |
| Kaveri Seed | 983.30 |
| Regaal Resources | 97.07 |
| Simran Farms | 169.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: